# MDCO-216 Infusions Leading to Changes in Atherosclerosis: A Novel Therapy in Development to Improve Cardiovascular Outcomes - Proof of Concept Intravascular Ultrasound (IVUS), Lipids, and Other Surrogate Biomarkers Trial

Study · id `cardio:ct-nct02678923` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02678923](<https://clinicaltrials.gov/study/NCT02678923>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02678923

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 126 participants.

## Technical summary

Registry record NCT02678923. Randomized; triple masking; primary purpose treatment. Start 2015-12-03 (actual); primary completion 2016-10-26 (actual). Results posted on 2017-07-13.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 1/2
- Enrolled: 126 participants (enrolled count; ClinicalTrials.gov record NCT02678923, source copy `cardio:ctgov-nct02678923-2017-07-13`, retrieved 2026-10-31)
- Started: 2015-12-03 (actual) (ClinicalTrials.gov record NCT02678923, source copy `cardio:ctgov-nct02678923-2017-07-13`, retrieved 2026-10-31)
- Primary completion: 2016-10-26 (actual) (ClinicalTrials.gov record NCT02678923, source copy `cardio:ctgov-nct02678923-2017-07-13`, retrieved 2026-10-31)
- Completion: 2016-10-26 (actual) (ClinicalTrials.gov record NCT02678923, source copy `cardio:ctgov-nct02678923-2017-07-13`, retrieved 2026-10-31)
- Results first posted: 2017-07-13 (ClinicalTrials.gov record NCT02678923, source copy `cardio:ctgov-nct02678923-2017-07-13`, retrieved 2026-10-31)
- Countries: Canada; Czechia; Hungary; Netherlands; Poland (ClinicalTrials.gov record NCT02678923, source copy `cardio:ctgov-nct02678923-2017-07-13`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02678923-2017-07-13`, retrieved 2026-10-31)

## The registry's words

- Brief title: MDCO-216 Infusions Leading to Changes in Atherosclerosis: A Novel Therapy in Development to Improve Cardiovascular Outcomes - Proof of Concept Intravascular Ultrasound (IVUS), Lipids, and Other Surrogate Biomarkers Trial
- Acronym: PILOT
- Condition: Acute Coronary Syndrome
- Intervention (Drug): MDCO-216
- Intervention (Drug): Placebo
- Lead sponsor: The Medicines Company
- Lead sponsor class: INDUSTRY
- Collaborator: The Cleveland Clinic
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: The Medicines Company (`cardio:org-the-medicines-company`)
- Registry lists this organization as a collaborator: The Cleveland Clinic (`cardio:org-the-cleveland-clinic`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial (`cardio:pubmed-30046837`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: d0b27707cbd886f0c17628d9754ab79be0a504aacc9d88097df373f903a305e9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
